有机锡9-芴酮-4-甲酸酯的合成、结构及抗癌活性

合成了3个有机锡9-芴酮-4-甲酸酯:三苯基锡9-芴酮-4-甲酸酯[(C₆H₅)₃Sn(C₁₄H₇O₃)](1)、三环己基锡9-芴酮-4-甲酸酯[(C₆H₁₁)₃Sn(C₁₄H₇O₃)](2)和三(2-甲基-2-苯基丙基)锡9-芴酮-4-甲酸酯[(C₆H₅C(CH₃)₂CH₂)₃Sn(C₁₄H₇O₃)](3)。通过元素分析、红外光谱、核磁共振谱(¹H、¹³C和¹¹⁹Sn)、热重分析进行了表征;用单晶X射线衍射方法测定了化合物的晶体结构,并对其进行了量子化学计算和体外抗...     

有机锡9-芴酮-4-甲酸酯的合成、结构及抗癌活性

合成了 3 个有机锡 9-芴酮-4-甲酸酯:三苯基锡 9-芴酮-4-甲酸酯[(C₆H₅)₃Sn(C₁₄H₇O₃)] (1)、三环己基锡 9-芴酮-4-甲酸酯[(C₆H₁₁)₃Sn(C₁₄H₇O₃)] (2)和三(2-甲基-2-苯基丙基)锡 9-芴酮-4-甲酸酯[(C₆H₅C(CH₃)₂CH₂)₃Sn(C₁₄H₇O₃)] (3)。通过元素分析、红外光谱、核磁共振谱(¹H、¹³C和 ¹¹⁹Sn)、热重分析进行了表征;用单晶X射线衍射方法测定了化合物的晶体结构,并对其进行了量子化学计算和体外抗癌活性研究。结果显示:化合物1为一维链状结构,中心锡原子为五配位的畸变三角双锥构型;化合物2和3均为单核分子,锡原子均为四配位的畸变四面体构型。化合物对人宫颈癌细(HeLa)、人肝癌细胞(HUH-7)、人非小细胞肺癌细胞(A549)、人肺腺癌细胞(H1975)和人乳腺癌细胞(MCF-7)都有较好的抑制活性。     

Organotin complexes of pyruvic acid thiosemicarbazone: Synthesis,crystal structures and antiproliferative activity of neutral and cationic diorganotin complexes

The synthesis and spectral characterization of novel neutral and cationic organotin complexes with pyruvic acid thiosemicarbazone, H₂pt (1), [SnPh₂(pt)] (2), [SnMe₂(Hpt)(H₂O)]Cl (3) and [SnPh₂(Hpt)(H₂O)]Cl (4) are reported. The crystal structure of the complexes [SnPh₂(pt)] (2) and [SnMe₂(Hpt)(H₂O)]Cl (3) have been solved by single-crystal X-ray diffraction. The crystal structure of complex 2 showed that the ligand is doubly deprotonated at the oxygen and amide nitrogen atoms and is coordinated to the SnPh₂ fragment via two five-membered chelate rings. The monomers of 2 are linked through intermolecular hydrogen bonds of C−H–O type and through π−π intermolecular interactions. The crystal structure of [SnMe₂(Hpt)(H₂O)]Cl (3) showed that the ligand is mono-deprotonated at the oxygen atom and is coordinated to the SnMe₂ fragment via two five-membered chelate rings. The counter ion chloride is participated in intermolecular hydrogen bonds. An extended network of intermolecular hydrogen bonds leads to aggregation and a supramolecular assembly. The IR and NMR spectroscopic data of the complexes are reported. The in vitro cytotoxic activity has been evaluated against the cells of three human cancer cell lines: MCF-7 (human breast cancer cell line), T-24 (bladder cancer cell line), A-549(non-small cell lung carcinoma) and a mouse L-929 (a fibroblast-like cell line cloned from strain L). The most active of all was found the diorganotin complex 2. The cytotoxic activity shown by these compounds against all these cancer cell lines indicates that coupling of 1 with R₂Sn(IV) metal center result in metallic complexes with important biological properties and remarkable cytotoxic activity, since they are display IC₅₀ values in a μM range the same or better to that of the antitumor drug cisplatin. Compound 2 is considered as agent with potential antitumor activity, and can therefore be candidate for further stages of screening in vitro and/or in vivo.     

Synthesis,structural characterization and in vitro cytotoxicity of diorganotin complexes with Schiff base ligands derived from 3‐hydroxy‐2‐naphthoylhydrazide

A series of diorganotin complexes with Schiff base ligands, (E)‐N′‐(5‐bromo‐2‐hydroxybenzylidene)‐3‐hydroxy‐2‐naphthohydrazide, H₂L1, and (E)‐N′‐(5‐chloro‐2‐hydroxybenzylidene)‐3‐hydroxy‐2‐naphthohydrazide, H₂L2, were synthesized and characterized by elemental analysis, IR, ¹H, ¹³C and ¹¹⁹Sn NMR spectroscopy. The molecular structures of the complexes, [(5‐bromo‐2‐oxidobenzylidene)‐3‐hydroxy‐2‐naphthohydrazidato]di(o‐chlorobenzyl)tin(IV) 6 and [(5‐chloro‐2‐oxidobenzylidene)‐3‐hydroxy‐2‐naphthohydrazidato]dibutyltin(IV) 9, were determined through single‐crystal X‐ray diffraction and revealed a distorted trigonal‐bipyramidal configuration. The in vitro cytotoxic activity of the Schiff bases and their diorganotin complexes was also evaluated against several human carcinoma cell lines, namely HT29 (human colon carcinoma cell line), SKOV‐3 (human ovarian cancer cell line), MCF7 (hormone‐dependent breast carcinoma cell line) and MRC5 (non‐cancer human fibroblast cell line). [(5‐Bromo‐2‐oxidobenzylidene)‐3‐hydroxy‐2‐naphthohydrazidato]dibutyltin(IV) 2 and [(5‐bromo‐2‐oxidobenzylidene)‐3‐hydroxy‐2‐naphthohydrazidato]dibenzyltin(IV) 5 were the most active diorganotin complexes of H₂L1 ligand. Among the diorganotin complexes of H₂L2 ligand, [(5‐chloro‐2‐oxidobenzylidene)‐3‐hydroxy‐2‐naphthohydrazidato]dicyclohexyltin(IV) 11 showed good cytotoxic activity against all the tested cell lines. As such, the above compounds can be considered agents with potential anticancer activities, and can therefore be investigated further in in vitro or in vivo anticancer studies. Copyright © 2012 John Wiley & Sons, Ltd.     

New organotin supramolecular complexes based on copper cyanide and auxiliary N‐donor ligands as potent inhibitors of cancer cell lines: In vitro and antioxidant experiments

The new synthesized supramolecular complexes (SC); [Cu₂(CN)₄(Et₃Sn)₂(tbpe)], 1 and [Cu₂(CN)₃(Et₃Sn)(bpe)], 2 (tbpe = trans‐1,2‐bis(4‐pyridyl)ethene and bpe = 1,2‐bis(4‐pyridyl)ethane), were characterized by elemental analyses, electrical conductance, spectroscopic studies and thermal analyses. UV–Vis spectra and magnetic moment data suggested the tetrahedral geometry around Cu(I) atoms. The structures of the SC 1 and 2 were also theoretically studied using molecular mechanics (MM+). The structures were minimized with a semi‐empirical (PM3) method. The organotin compounds represent significant advances in the clinical management of some cancer cell lines. 1 and 2 were tested as inhibitors and their citotoxicities showed potent growth inhibitory activity for hepatocellular carcinoma HePG‐2, mammary gland breast cancer MCF‐7, human prostate cancer PC3 and Colorectal carcinoma HCT‐116 cell lines. The tested compounds showed high inhibitory anti‐oxidant activity either using erythrocyte hemolysis or ABTS method.     

Structure and in vitro antifungal activity of [2,6‐bis(dimethylaminomethyl)phenyl]diphenyltin(IV) compounds

A set of seven [2,6‐bis(dimethylaminomethyl)phenyl]diphenyltin(IV) ({[(CH₃)₂NCH₂]₂(C₆H₃)}­(C₆H₅)₂Sn⁺X^?) ionic organotin(IV) compounds (X = Br, NO₃, CN, SCN, SeCN, BF₄ and PF₆) has been prepared and characterized by electrospray ionization mass spectrometry, ¹H NMR spectroscopy in CDCl₃,¹¹⁹Sn NMR in CDCl₃ and DMSO‐d₆ solution, as well as by ¹³C and ¹¹⁹Sn CP/MAS NMR spectroscopy and X‐ray diffraction techniques in the solid state. The in vitro antifungal activity of these water‐soluble ionic organotin(IV) compounds was compared with starting compounds and the antifungal drugs currently in clinical use. Copyright © 2002 John Wiley & Sons, Ltd.     

Synthesis,spectral analysis and in vitro cytotoxicity of diorganotin (IV) complexes derived from indole-3-butyric hydrazide

A series ( 1–20 ) of diorganotin (IV) complexes with general formula R₂SnL were formed by the reaction of R₂SnCl₂ (where R = Me, Et, Bu and Ph) with Schiff base ligands ( H ₂ L ^1–4 ) derived from the reaction of indole-3-butyric hydrazide with the salicylaldehyde and its derivatives. The structure elucidation of compounds were done by using UV–Vis, FT-IR, NMR (¹H, ¹³C, ¹¹⁹Sn), Mass spectrometry and thermal gravimetric analysis. Spectroscopic evidences suggested tridentate nature (ONO) of Schiff base ligands and coordinated to the dialkyl/diaryltin (IV) moieties through nitrogen and oxygen donor sites giving pentacoordinated geometry to complexes. The compounds were tested for the antimicrobial activity against bacterial and fungal strains which showed promising biological activity with compound 20 (Ph₂SnL⁴) as most active against microbes. The in silico study of the compounds was carried and observed that the compounds are used as orally active drugs and promote the formation of different hydrazide based drugs. The synthesized compounds were tested against human carcinoma cell lines namely A549, MCF7 and one normal cell line IMR 90 using MTT assay. The diethyl and dibutyltin complexes of Schiff bases displayed good cytotoxic activities. Compound 3 (H₂L³) and 10 (Et₂SnL²) were most potent against cancer cell lines with lowest IC₅₀ values and 7–8 times less toxic against the normal cell line.     

New mononuclear diorganotin(IV) dithiocarboxylates: synthesis,characterization and study of their cytotoxic activities

Since organotin complexes have been reported to show fewer side effects relative to other heavy metal anticancer compounds, in the present study we report for the first time four novel organotin(IV) derivatives with the general formula R₂SnL₂, where R = methyl (1), n‐butyl (2), phenyl (3), benzyl (4) and L = morpholine‐1‐carbodithioate (MCDT). The newly synthesized ligand was monodentate or bidentate, coordinating through a sulfur atom. The complexes were synthesized by directly mixing, refluxing and stirring the ligand, with diorganotin(IV) dichlorides in a suitable solvent. The complexes were found to be pure and their solid and solution phase structural configuration was investigated by FT‐IR, multinuclear NMR (¹ H, ¹³ C, ¹¹⁹Sn) and mass spectrometry. Complex 2 was also studied for its thermal decomposition by thermogravimetry and differential thermal analysis. The results obtained on the basis of these techniques are in full concurrence with the proposed 1:2 (Sn:L) stoichiometry. The cytotoxic activity of the MCDT and diorganotin(IV) complexes (1–4) was tested against tumor cell lines – human cervix carcinoma HeLa and human myelogenous leukemia K562 – and normal immunocompetent cells: peripheral blood mononuclear cells PBMC. Results of bioassay demonstrated that organotin derivatives were in general more active than the anticancer drug cisplatin. Copyright © 2012 John Wiley & Sons, Ltd.     

两个苯甲羟肟酸有机锡配合物的合成、结构及抗癌活性

合成了2个苯甲羟肟酸有机锡配合物：[(o-Cl-C₆H₄CH₂)₂Sn (C₆H₅CONO)₂](1)和[(o-CH₃-C₆H₄CH₂)₂Sn (C₆H₅CONO)(C₆H₅COO)](2)。通过元素分析、红外光谱、核磁共振氢谱、热重分析、单晶X射线衍射等方法对配合物进行了结构表征,对其结构进行量子化学从头计算和体外抗癌活性研究。结果显示：配合物均为单锡核结构,配合物1为六配位的畸变八面体构型,配合物2为五配位的畸变三角双锥构型;配合物1对人宫颈癌细胞(HeLa)、肝癌细胞(HuH-7)和肺腺癌细胞(H1975)显示出比临床使用的顺铂强的抑制活性,而配合物2的抑制活性要弱得多。     

The in vitro antifungal activity of some dithiocarbamate organotin(IV) compounds on Candida albicans— a model for biological interaction of organotin complexes

The in vitro antifungal activity of the dithiocarbamate organotin complexes [Sn{S₂CN(CH₂)₄}₂Cl₂] ( 1 ), [Sn{S₂CN(CH₂)₄}₂Ph₂] ( 2 ), [Sn{S₂CN(CH₂)₄}Ph₃] ( 3 ), [Sn{S₂CN(CH₂)₄}₂n‐Bu₂] ( 4 ), [Sn{S₂CN(CH₂)₄}Cy₃] {Cy = cyclohexyl} ( 5 ), [Sn{S₂CN(C₂H₅)₂}₂Cl₂] ( 6 ), [Sn{S₂CN(C₂H₅)₂}₂Ph₂] ( 7 ), [Sn{S₂CN(C₂H₅)₂}Ph₃] ( 8 ), [Sn{S₂CN(C₂H₅)₂}₃Ph] ( 9 ) and [Sn{S₂CN(C₂H₅)₂}Cy₃] ( 10 ) has been screened against Candida albicans (ATCC 18804), Candida tropicalis (ATCC 750) and resistant Candida albicans collected from HIV‐positive Brazilian patients with oral candidiasis. All compounds exhibited antifungal activities and complexes 3 and 8 displayed the best results. We have investigated the effect of compounds 1–10 on the cellular activity of the yeast cultures. Changes in mitochondrial function have not been detected. However, all drugs reduced ergosterol biosynthesis. Preliminary studies on DNA integrity indicated that the compounds do not cause gross damage to yeast DNA. The data suggest that these compounds share some mechanisms of action on cell membranes similar to that of polyene but not with azole drugs, normally used in Candida infections. Copyright © 2008 John Wiley & Sons, Ltd.     

Synthesis,structural characterization and in vitro cytotoxic activity of novel polymeric triorganotin(IV) complexes of urocanic acid

Two novel triorganotin carboxylate complexes of the biologically active urocanic acid have been synthesized and characterized. Elemental analysis, melting point, spectroscopic techniques – IR, ¹H, ¹³C and ¹¹⁹Sn NMR – mass spectrometry and X‐ray diffraction studies have been used for structural characterization. Crystal structures of the tin(IV) derivatives show that urocanic acid acts as a bridging bidentate ligand through its imidazole nitrogen atom and its carboxylic group, producing a polymeric one‐dimensional chain. The molecular structures of the complexes, catena‐poly‐tri(n‐butyl)tin(IV) 3‐(3H‐imidazol‐4‐yl)prop‐2‐enoate (1) and catena‐poly‐triphenyltin(IV) 3‐(3H‐imidazol‐4‐yl)prop‐2‐enoate (2), present a distorted trigonal–bipyramidal configuration. This is further confirmed by ¹¹⁹Sn NMR in the solid state. The tin(IV) derivatives form double‐stranded ribbons via N―H^…O―H bonds. Nevertheless, the compounds are essentially monomeric in solution, with a tetrahedral configuration as observed by ¹¹⁹Sn NMR in solution. The cytotoxic activity of the titled compounds has been tested against six human cell lines and the corresponding IC₅₀ values are reported. Both tin(IV) compounds have a high to very high in vitro cytotoxic activity against the tumor cell lines K562, HCT‐15 and MCF‐7. Compound 1 is 86 times more active than cisplatin in the HTC‐15 cell line. Copyright © 2012 John Wiley & Sons, Ltd.     

Mononuclear diorganotin(IV) complexes with arylhydroxamates: syntheses,structures and assessment of in vitro cytotoxicity

Two series of diorganotin(IV) complexes with dihalogenobenzohydroxamate ligands (substituents = 2,4‐Cl₂, 2,4‐F₂, 3,4‐F₂, 2,5‐F₂, 2,6‐F₂), formulated as [R₂Sn(HL)₂] ( a ), and the arylhydroxamato/arylcarboxylato mixed‐ligand complexes [R₂Sn(HL)(L′)] ( b ), were prepared and characterized by FT‐IR, ¹H, ¹³C and ¹¹⁹Sn NMR spectroscopies, elemental analyses and melting point measurements. X‐ray diffraction analysis was also carried out for the complex [Me₂Sn{3,4‐F₂C₆H₃C(O)NHO}₂], 1a . These compounds exhibit in vitro cytotoxic activities towards human leukemic promyelocites HL‐60, BGC‐823, BEL‐7402 and KB cell lines which, in some cases, are identical to, or even higher than, that of cisplatin. The type, position and number of the X substituents in the phenyl ring play a role in the cytotoxic activity, and complex 8a , with its 2,6‐difluorobenzohydroxamato ligand, is highly active against all tumor cells. A tentative structure–activity relationship is also described. Copyright © 2007 John Wiley & Sons, Ltd.     

A novel bidentate ligand containing oxime,hydrazone and indole moieties and its BF2+ bridged transition metal complexes and their efficiency against prostate and breast cancer cells

In this study, a novel bidentate ligand containing oxime, hydrazone, and indole moieties and its BF₂⁺-bridged transition metal complexes [Ni(II), Cu(II), and Co(II)] were synthesized and their cytotoxic activities against prostate and breast cancer cells were investigated. The vic-dioxime ligand bearing indole–hydrazone side groups was synthesized by reacting antiglyoximehydrazine (GH₂) with 3-methoxy indole. The ligand forms mononuclear complexes with a metal-to-ligand ratio of 1:2 with M = Co(II)(H₂O)₂, Ni(II), and Cu(II). These metal complexes were then reacted with BF₃(C₂H₅)₂O to obtain BF₂⁺-bridged transition metal complexes. The Co(II) complex of the ligand is proposed to be octahedral with water molecules as axial ligands, whereas the Ni(II) and Cu(II) complexes are proposed to be square planar. Spectral studies showed that the ligand bonded to the metal ion in a neutral bidentate fashion through the azomethine nitrogen atom and the imine oxime group. Structural assignments are supported by a combination of ¹H nuclear magnetic resonance (NMR), ¹³C NMR, Fourier-transform infrared, LC/MS, elemental analyses, and magnetic susceptibility testing. For determining the cytotoxic effects of the novel anticancer products, cancer cells were cultured. The antiproliferative effects were determined using the MCF-7 breast cancer and PC-3 prostate cancer cell lines. The antiproliferative effects of the products were analyzed and their apoptotic or necrotic effects were determined with the Hoechst/propidium iodide double staining method in both cancer cell lines. Paclitaxel was used as the positive control (1 μm ). The results indicated that the newly synthesized compounds are effective on both cell lines between concentrations of 5 and 40 μm and show their effects by apoptotic mechanisms. Besides, these products were found to be more effective on the MCF-7 cell line. The cytotoxic efficiency of the newly synthesized products was more than that of paclitaxel (depending on concentration), which is a chemotherapeutic agent used in cancer therapy.     

Biological aspects of new organotin(IV) compounds of 3-maleimidopropionic acid

Four new compounds of organic mono carboxylic acid, 3-maleimidopropionic acid; with Bu₂Sn(IV)²⁺, Ph₃Sn(IV)⁺ and Cychex₃Sn(IV)⁺ having ligand to metal ratio 1:2 and 1:1 were prepared. The spectrophotometric techniques used for structure determination like ¹H-, ¹³C- and ¹¹⁹Sn-NMR, FT IR and ^119mSn Mössbauer have demonstrated that the organotin(IV) moieties establish chemical bonding with the ligand through carboxylic oxygen atom. The percent CHN analyses and MS data also corroborates the spectroscopic results. During in vitro LD₅₀, anti-fungal, anti-bacterial and anti-yeast bioassays promising results were exhibited. In vitro anti-tumour activity assays against five human tumor cell lines, MCF-7 Breast cancer-EVSA-T Breast cancer-WiDr Colon cancer-IGROV Ovarian cancer-M226 Non small cell lung cancer and anti-inflammatory screenings furnished the significant toxicities of the title complexes. In addition the triorganotin(IV) complexes were comparatively less toxic than the diorganotin(IV) complexes.     

Synthesis,characterization, and anticancer activity of some azole‐heterocyclic complexes with gold(III), palladium(II), nickel(II), and copper(II) metal ions

Four new complexes of Au(III), Pd(II), Ni(II), and Cu(II) ions were synthesized, derived from a novel heterocyclic ligand (L) that has both triazole and tetrazole rings. The ligand synthesis was through successive steps to achieve both heterocyclic rings. The synthesized compounds were characterized using conventional techniques like infrared, ultra violet—visible and proton/carbon nuclear magnetic resonance spectroscopy, metal and thermal analyses, and molar conductivity. All complexes were suggested to have square planar geometry, gold, nickel, and palladium complexes were salts while copper neutral complexes have the chemical formulas; [AuL₂]Cl.2H₂O, [PdL₂]Cl₂.2H₂O, [NiL₂]Cl₂.2H₂O, and [CuL₂]. The cytotoxic effect was studied on breast cancer cell line (MCF‐7 cell line) at different concentrations by using the 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide assay method, for the ligand (L) and complexes. The results showed that gold(III) and nickel(II) complexes have the highest cytotoxicity among all compounds against cancer cell lines.     

Structure and cytotoxicity of zinc (II) and cobalt (II) complexes based on 1,3,5‐tris(1‐imidazolyl) benzene

Three novel complexes, [Zn (tib)₂·(H₂O)₂]·(NO₃)₂ ( 1 ), [Co (tib)₂]·2NO₃ ( 2 ) and [Co₂(tib)₂(btc)]·H₂O ( 3 ) [H₄btc = 1,2,4,5‐benzenetetracarboxylic acid; H₂tib = 1,3,5‐tris(1‐imidazolyl)benzene], were synthesized and characterized by single‐crystal X‐ray, IR and elemental analysis. The interaction of these complexes with FS‐DNA (fish sperm DNA) was monitored, and binding constants were determined using UV/Vis, which revealed that they have the ability to bind to FS‐DNA. DNA‐binding constants (K) for the three complexes were 2.2 × 10⁴ m ^?1, 0.7 × 10⁴ m ^?1 and 0.09 × 10⁴ m ^?1, respectively. The interaction capacity of the complexes with FS‐DNA has been investigated by fluorescence spectroscopy. Stern–Volmer quenching plot values for complexes 1 , 2 and 3 were 0.3784, 0.1028 and 0.076, respectively. The viscosity measurement suggested that complexes 1 , 2 and 3 interact with DNA in an intercalation mode. In addition, anti‐cancer activities of these complexes investigated through MTT assays in vitro indicated that the complexes showed good cytotoxic activity against cancer cell lines. Cytotoxic activity of test complexes against two different cancer cell lines (HeLa and KB cells) showed significant cancer cell inhibition rates. Flow cytometry experiments and morphological apoptosis studies showed that the complexes induced apoptosis of HeLa tumor cell lines. Finally, a further molecular docking technique was employed to confirm the binding of the complexes toward the molecular target DNA.     

Synthesis,characterization, molecular docking and biological activity of 5,6-bis-(4-fluoro-phenyl)-3,4,7,8-tetraaza-bicyclo[8.3.1]tetradeca-1(13),4,6,10(14),11-pentaene-2,9-dione and its transition metal complexes

Macrocyclic Schiff base ligand through the condensation of 1,3-dicarbonyl-phenyl-dihydrazide with 4,4′-difluorobenzil and its Co(II), Ni(II), Cu(II) and Zn(II) metal complexes have been synthesized. The ligand and metal complexes were characterized by analytical and physicochemical methods. An octahedral geometry arising from coordination of N2O2 donor atoms from the macrocyclic framework has been proposed for all metal complexes. Synthesized ligand and metal complexes were investigated for in vitro antibacterial and antioxidant activity. Complex [Ni(C₂₂H₁₄N₄F₂O₂)(OCOCH₃)₂] has shown remarkable antibacterial activity (Minimum inhibitory concentration 8–16?μg/ml) comparable to commercial antibiotic Ciprofloxacin. Anticancer activity of synthesized compounds against Squamous Cell Carcinoma (SCC4), head and neck cancer cell line has also been studied at different concentrations and at different time points. Complexes [Co(C₂₂H₁₄N₄F₂O₂)(NO₃)₂] and [Cu(C₂₂H₁₄N₄F₂O₂)(OCOCH₃)₂] have shown remarkable anticancer results (IC₅₀ 31.1 and 43.1?μM) against the tested cell line in concentration dependent manner. Molecular docking studies were carried out to find the binding mode of the synthesized macrocyclic Schiff base ligand to Epidermal Growth Factor Receptor (EGFR) Kinase (PDB ID: 1M17).     

Synthesis,spectral and pharmacological studies on lanthanide(III) complexes of 3,5-pyrazoledicarboxylic acid

Complexes of cerium(III), lanthanum(III) and neodymium(III) with 3,5-pyrazoledicarboxylic acid (H₃pdc) were synthesized and their compositions determined by elemental analysis. To identify the binding of Ce(III), La(III) and Nd(III) with H₃pdc, detailed vibrational analysis was performed comparing experimental vibrational spectra of the ligand and its Ln(III) complexes with theoretically predicted and with literature data from related compounds. Significant differences in the IR and Raman spectra of the complexes were observed as compared to spectra of the ligand. The ligand and the complexes were tested for cytotoxic activities on the chronic myeloid leukemia derived K-562, overexpressing the BCR-ABL fusion protein and the non-Hodgkin lymphoma derived DOHH-2, characterized by an overexpression of the antiapoptotic protein bcl-2 cell lines. The results indicate that the tested compounds exerted considerable cytotoxic activity upon the evaluated cell lines in a concentration dependent manner; we constructed dose-response curves and calculated corresponding IC₅₀ values. The lanthanide complexes exhibited potent cytotoxic activity, even more than cisplatin towards K-562 and DOHH-2 cell lines. In order to elucidate some of the mechanistic aspects of the observed cytotoxic effects, we evaluated whether the established cytotoxicity of the most active complex La(H₂pdc) is related to its capacity to induce cell death through apoptosis.     

Synthesis and biological activity of trinuclear seven-coordinated tin(IV) complexes derived from tridentate ligands and trimesic acid

The synthesis of trinuclear Sn(IV) complexes 5a–h – prepared in a one-pot reaction of 2-amino-4-R-phenol (R=H, Me, Cl, NO₂), 2-pyridine-carboxaldehyde, 1,3,5-benzenetricarboxylic acid (trimesic acid, H₃BTC), and dibutyl and dioctyltin oxides – is described. These compounds were characterized by elemental analysis, mass spectrometry, IR, and multinuclear NMR spectroscopy. The structures of 5a and 5b were also determined by single-crystal X-ray analysis. The trinuclear tin system is formed by bridges through the carboxylate moieties. The metal centers are seven-coordinate and the coordination polyhedron of tin can be depicted as distorted pentagonal-bipyramidal (PBP), where the equatorial plane consists of three oxygens and two nitrogens and the organic groups occupy the axial positions. The work presented here combines the useful properties of Schiff bases and H₃BTC ligands in the formation of organotin(IV) complexes, and investigates the likely antioxidant (DPPH and TBARS) and anti-inflammatory activity (TPA) of the new substances.